Browsing by Author APOSTOLIDIS Christos

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 87 to 106 of 118 < previous   next >
Publication YearJRC Publication N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2001JRC22316Structure and Properties of Hydrated La(III), Nd(III) and Er(III) Methanosulfonates.ARICO E.m.; ZINNER L.b.; KANELLAKOPOULOS Basil; DORNBERGER Ernst; REBIZANT Jean; APOSTOLIDIS ChristosArticles in Journals
1997JRC15505Structures of the Anhydrous Yb(III) and the Hydrated Ce(III), Sm(III) and Tb(III) Methanesulfonates.ARICO E.m.; ZINNER L.b.; APOSTOLIDIS Christos; DORNBERGER Ernst; REBIZANT JeanArticles in Journals
2000JRC19824Studies on the Red Marrow Dosimetry in Radioimmunotherapy. An Experimental Investigation of Factors Influencing the Radio-Induced Myelotoxicity in Therapy with beta-, Auger/Conversion Electron-, or alpha-Emitters.BEHR T.m.; SGOUROS G.; STABIN M.g.; BEHE M.; ANGERSTEIN Ch.; BLUMENTHAL R.d.; APOSTOLIDIS Christos; MOLINET Roger; SHARKEY R.m.; KOCH Lothar, et alArticles in Journals
2005JRC26180Synergistic Antitumor Effects of alpha-Radioimmunotherapy and Paclitaxel or Doxorubicin on Human Myeoloma Cells.SUPIOT S.; FAIVRE-CHAUVET A.; THILLAYS F.; GOUARD S.; APOSTOLIDIS Christos; WIJDENES John; BARBET J.; BATAILLE R.; DAVODEAU F.; CHEREL M.Articles in Journals
2012JRC71710Synthesis and in vitro evaluation of 225Ac-DOTA-SubstanceP for targeted alpha therapy of glioblastoma multiformeMAJKOWSKA AGNIESZKA; BRUCHERTSEIFER Frank; WEIS Mirjam; BONELLI Milton; LAURENZA M; APOSTOLIDIS Christos; MORGENSTERN AlfredContributions to Conferences
1998JRC17598Synthesis and Magnetic Properties of (C5H5)3Ce-Center-HMPA.ARICO E.m.; APOSTOLIDIS Christos; ZINNER L.b.Articles in Journals
2013JRC80486Synthesis of 213Bi-DOTATOC for peptide receptor a-therapy of GEP-NET patients refractory to β-therapyBRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; GIESEL Frederik; MIER Walter; HABERKORN Uwe; KRATOCHWIL ClemensContributions to Conferences
2012JRC72901Synthesis of 213Bi-DOTATOC for peptide receptor alpha-therapy of GEP-NET patients refractory to beta therapyMORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; GIESEL Frederik; MIER Walter; HABERKORN Uwe; KRATOCHWIL ClemensContributions to Conferences
2000JRC21185Synthesis of a Novel Bifunctional Chelating Agent for Actinium Complexation.QUADI Ali; LOUSSOUARN A.; REMAUD P.; MORANDEAU L.; APOSTOLIDIS Christos; MUSIKAS C.; FAIVRE-CHAUVET A.; GESTIN J.-f.Articles in Journals
2010JRC53275Synthesis of Bimetallic Uranium and Neptunium Complexes of a Binucleating Macrocycle and Determination of the Solid-State Structure by Magnetic AnalysisARNOLD Polly L.; POTTER Natalie A.; MAGNANI Nicola; APOSTOLIDIS Christos; GRIVEAU Jean-Christophe; COLINEAU Eric; MORGENSTERN Alfred; CACIUFFO Roberto; LOVE Jason B.Articles in Journals
2013JRC80175Synthesis of transuranium-based nanocrystals via the thermal decomposition of actinyl nitratesHUDRY DAMIEN; APOSTOLIDIS Christos; WALTER OLAF; GOUDER Thomas; JANSSEN ARNE; COURTOIS Eglantine; KUEBEL Christian; MEYER D.Articles in Journals
2013JRC81654Targeted alpha therapy of glioblastoma multiforme with 213Bi-substance PMORGENSTERN Alfred; KROLICKI Leszek; KUNIKOWSKA Jolanta; KOCIARA Henryk; KROLICKI B; JAKUCINSKI M; MIKOŁAJCZAK Renata; PAWLAK Dariusz; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankContributions to Conferences
2014JRC88673Targeted alpha therapy of glioblastoma multiforme: First clinical experience with 213Bi-substance PMORGENSTERN Alfred; KROLICKI Leszek; KUNIKOWSKA Jolanta; KOZIARA H; KROLICKI B; JAKUCINSKI M; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankContributions to Conferences
2013JRC82711Targeted alpha therapy of glioblastoma multiforme: initial clinical experience with 213Bi-substance PMORGENSTERN Alfred; KROLICKI Leszek; KUNIKOWSKA Jolanta; KOZIARA H; KROLICKI B; JAKUCINSKI M; MIKOŁAJCZAK Renata; PAWLAK Dariusz; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankContributions to Conferences
2005JRC28667Targeted Alpha Therapy with 213 Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic Cancer.QU Chang f.; SONG Yang j.; LI Yong; RIZVI S.m.a.; RAJA Chand; SMITH R.; MORGENSTERN A.; APOSTOLIDIS Christos; ALLEN B.j.Articles in Journals
2011JRC64087Targeted alpha therapy with 213BiMORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS ChristosArticles in Journals
2010JRC56637Targeted Alpha-Radionuclide Therapy of Functionally Critical Located Gliomas with 213Bismuth-DOTA-[Thi8,Met(O2)11]-Substance P - A Pilot TrialCORDIER D.; FORRER F.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; GOOD S.; MÜLLER-BRAND J.; MÄCKE H.; REUBI Jean-Claude; MERLO A.Articles in Journals
2014JRC83534Thorium / Uranium Mixed Oxide Nanocrystals: Synthesis, Structural Characterization and Magnetic PropertiesHUDRY DAMIEN; GRIVEAU Jean-Christophe; APOSTOLIDIS Christos; WALTER OLAF; COLINEAU Eric; RASMUSSEN Gert; WANG Di; CHAKRAVADHALUNA Kiran; COURTOIS Eglantine; KUEBEL Christian, et alArticles in Journals
2014JRC88670Treatment of bladder cancer with Bi-213-anti-EGFR-MAb – a pilot studySCHEIDHAUER Klemens; SEIDL C.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; AUTENRIETH Michael; KURTZ F; ESSLER M.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2012JRC69021Triclinic-cubic phase transition in actinide diphosphates AnP2O7 (An=Th, U, Np, Pu). Structural investigation by synchrotron radiation and solid-state NMRWALLEZ G; POPA Karin; BREGIROUX D.; BYKOV DENIS; DACHEUX Nicolas; CLAVIER Nicolas; KONINGS Rudy; FITCH Andrew; DELEVOYE L.; APOSTOLIDIS Christos, et alContributions to Conferences